Global Cryostat Market Overview (2022–2030)

According to insights from Custom Market Insights (CMI), the global cryostat market was valued at approximately USD 2 billion in 2021 and is projected to reach USD 3.1 billion by 2030, growing at a steady compound annual growth rate (CAGR) of 5% during the forecast period from 2022 to 2030.

The report provides a comprehensive 4.5-degree evaluation of the key market drivers, challenges, and restraints, and examines the influence these factors have on market demand across various sectors. Additionally, the study highlights emerging global opportunities and conducts a competitive landscape analysis of major players operating in the industry.

? Browse Full Report:
? Cryostat Market Report – Custom Market Insights

What Is a Cryostat?

A cryostat is a specialized device used to maintain ultra-low temperatures for various samples, most commonly in the fields of healthcare, biotechnology, and aerospace. These devices work by thermally isolating tissue or other materials from ambient temperature, utilizing a combination of:

• Vacuum insulation

• Radiation shields

• Superinsulation

• Low thermal conductivity materials

This combination limits heat transfer and helps achieve the required cryogenic conditions. Cryostats are also designed to prevent contamination from external particles, substances, or microorganisms, thereby preserving the sample’s integrity.

Market Growth Drivers

? 1. Increasing Medical Research Initiatives

A significant growth driver for the cryostat market is the rising investment in medical and clinical research, particularly for cancer, one of the top five global causes of death. The development of advanced treatments and diagnostic technologies has resulted in heightened demand for cryogenic devices like cryostats.

• As of November 2019, the National Library of Medicine (NLM) reported over 16,000 active clinical trials in the United States alone.

• The number of oncology-related clinical trials increased from 421 in 2000 to 1,489 in 2021, demonstrating robust research activity in the field.

Key pharmaceutical companies have significantly increased their RD budgets, for example:

• Pfizer Inc. invested $13.8 billion in RD in 2021, reflecting a 47% increase from the previous year.

• F. Hoffmann-La Roche AG (Roche) spent $16.1 billion in 2020, making it the top RD spender in the industry.

• Johnson Johnson boosted its research spending by 21% from $14.7 billion in 2020 to $19.7 billion in 2021.

These research efforts directly support the demand for cryostats, especially in laboratories requiring precision freezing, slicing, and preservation of biological samples.

⚙️ 2. Technological Advancements and Future Opportunities

Ongoing advancements in cryogenic engineering, material science, and biomedical equipment are creating new avenues for market expansion. Innovations in energy-efficient cooling systems, automated sample handling, and integration with digital diagnostics platforms are expected to fuel future adoption.

⚠️ 3. Market Restraint – High Helium Costs

Despite growth prospects, the high cost of helium—a commonly used cryogen in cryostats—remains a key challenge. As helium is rare and difficult to extract, price volatility and supply shortages could hinder market scalability, especially in cost-sensitive regions.

Segmental Overview

The cryostat market is segmented based on Type, Cryogen, System Component, and Application.

? By Type

• Closed-Cycle Cryostats

• Bath Cryostats

• Multistage Cryostats

• Continuous-Flow Cryostats (Dominant Segment)

In 2021, continuous-flow cryostats held the largest market share. These systems use liquid cryogens—primarily liquid helium or liquid nitrogen—from storage dewars to maintain consistent low temperatures.

• Cryogen flows into the cryostat and boils, cooling the sample while an integrated heater maintains the required balance.

• Helium dominated the cryogen segment with a 51% market share, thanks to its efficiency in maintaining temperatures near absolute zero, essential in many high-precision medical and scientific applications.

? By Cryogen

• Nitrogen

• Helium (Major Segment)

• Others

? By System Component

• Dewars

• Gas Flow Pumps

• Microtome Blades

• Transfer Tubes

• Temperature Controllers

• High Vacuum Pumps

• Others

These components are integral to the smooth operation, precision, and performance of cryostats, particularly in complex research environments.

? By Application

• Healthcare

• Aerospace

• Forensic Science

• Energy Power

• Metallurgy

• Biotechnology

• Marine Biology

• Others

Applications in healthcare and aerospace are currently driving the highest demand, owing to technological reliance on cryogenic systems for diagnostics, imaging, and space research.

Regional Overview

? North America – Leading Region

In 2021, North America emerged as the largest regional market, capturing approximately 34% of the global cryostat market share. This dominance is attributed to:

• Advanced infrastructure in healthcare and aerospace

• High demand for cryostats in applications such as MRI imaging, frozen tissue sectioning, exploratory surgeries, X-rays, and spectroscopy

• Presence of high-profile institutions like NASA, which uses cryostats in space exploration equipment such as the Wide-field Infrared Survey Explorer (WISE). WISE’s cryostat features a 2-stage solid hydrogen dewar to cool its optics and sensors.

? Other Key Markets

Countries in Europe and Asia-Pacific are also showing promising growth, especially with increasing investments in:

• Cancer research

• Biotechnology labs

• Cryogenic material handling

• Environmental research

Rapid industrialization and infrastructure development in China, India, South Korea, and Japan also support regional market growth.

Competitive Landscape

The cryostat market is characterized by strategic alliances, acquisitions, and partnerships aimed at expanding product portfolios and advancing technological capabilities.

? Recent Strategic Moves

• In June 2020, Thermo Fisher Scientific Inc. partnered with Schrödinger, Inc. to enhance cryo-electron microscopy (cryo-EM) usage in drug development.

• In February 2021, SLEE medical GmbH signed an exclusive distribution deal with Solmedia Limited (UK), granting Solmedia rights to distribute SLEE’s advanced cryostat systems in the UK.

Such collaborations are expected to accelerate market adoption and product development, especially in clinical diagnostics and academic research.

Key Market Players

Major companies operating in the global cryostat market include:

• Cryomech Inc.

• Bright Instruments

• Advanced Medical and Optical Systems

• Jinhua YIDI Medical Appliance Co. Ltd

• SLEE Medical GmbH

• Janis Research Company LLC

• Thermo Fisher Scientific Inc.

• Amos Scientific Pty Ltd

• Medimeas

• Atico Medical Pvt. Ltd.

• Advanced Research Systems Inc.

• Hacker Instruments Industries Inc.

• Histo-Line Laboratories

• Boeckeler Instruments Inc.

• Lupetec – Tecnologia Aplicada

• SCILAB Co Ltd

These players are engaged in innovations, product expansions, and partnerships that enable them to meet evolving user needs in precision freezing, tissue diagnostics, and cryogenic sample preservation.

https://www.custommarketinsights.com/report/cryostat-market/